Cancer.Net
Oncologist-approved cancer information from the American Society of Clinical Oncology
Oncologist-approved cancer information from the American Society of Clinical Oncology
1 – 20 out of 5893 Results for “2024 ASCO Annual Meeting” 5893 Results Select All Presenter: Jens Hoeppner, FAChirg, FACS, MD Presenter: Christian U.…
The American Society of Clinical Oncology (ASCO) announced four additional medical schools have been selected to participate in the Society’s Oncology Summer Internship (OSI) Program.
With improved survival benefits with ICIs and targeted therapies in metastatic NSCLC, the use of these agents has made its way into early-stage NSCLC.
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance…
Data from a single-arm phase 2 trial conducted in China showed that glecirasib produced a response rate of 48% in patients with advanced KRASG12C-mutated NSCLC…
Learn more about the faculty and program for the Monthly Plenary Series session.
ASCO’s new policy statement on SDOH supports practices that sustain and advance cancer health equity.